Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Fruquintinib for treating refractory metastatic colorectal cancer	Fruquintinib (Elunate; TAK113; HMPL013)	Colorectal cancer	Gastrointestinal Cancer , Oncology	2023	View \| Download
Futibatinib for treating cholangiocarcinoma with FGFR2 gene rearrangements	Futibatinib	Cholangiocarcinoma	Haematological Cancer and Lymphomas , Oncology	2023	View \| Download
Galcanezumab for preventing migraine in children	Galcanezumab (Emgality; LY-2951742)	Migraine	Neurology	2023	View \| Download
Galcanezumab for the prophylaxis of episodic and chronic migraine	Galcanezumab (Emgality; LY-2951742)	Migraine	Neurology	2017	View \| Download
Gantenerumab for Alzheimer’s disease	Gantenerumab	Alzheimer's disease	Neurology	2022	View \| Download
Garadacimab for preventing attacks of hereditary angioedema	Garadacimab	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2023	View \| Download
Garetosmab for preventing abnormal bone formation in fibrodysplasia ossificans progressiva	Garetosmab (REGN2477)	Fibrodysplasia ossificans progressiva	Musculoskeletal System	2020	View \| Download
Gefapixant for chronic refractory cough – First line	Gefapixant (MK-7264)	Idiopathic chronic cough	Respiratory System	2020	View \| Download
Gilteritinib for Relapsed or Refractory Acute Myeloid Leukaemia (AML) with an FLT3 Mutation – Second Line	Gilteritinib (ASP2215; Xospata; gilteritinib fumarate)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2018	View \| Download
Gilteritinib maintenance therapy for FLT3-ITD mutated acute myeloid leukaemia	Gilteritinib (ASP2215; Xospata; gilteritinib fumarate)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2022	View \| Download